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Résumé en
anglais
OBJECTIVE: To identify markers (phenotypic, genetic, or environmental) of blood
pressure (BP) response profiles to angiotensin converting enzyme inhibitors (ACEIs)
and diuretics. METHODS: IDEAL was a crossover (two active and two wash out
phases), double-blind, placebo-controlled trial. Eligible patients were untreated
hypertensive, aged 25 to 70. After two visits, patients were randomized to one of
four sequences. The main outcome was BP differences between the active treatment
and placebo. RESULTS: One hundred and twenty-four patients were randomised:
mean age 53, men 65%, family history of hypertension 60%. Average BP fall at each
visit before randomisation was about 2% of the initial level reflecting both a
regression to the mean and a placebo effect. CONCLUSION: The results are
expected to improve knowledge in drug's mechanisms of action and
pathophysiology of hypertension, and to help in personalizing treatment. The
estimation of BP responses to each drug in standardized conditions provided a
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